Analyst consensus rating
Odyssey Therapeutics Analyst Rating: Strong Buy
Direct answer
Odyssey Therapeutics's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $35.75.
Forecast evidence checked September 4, 2026.
Get free Odyssey Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $28.76
- Average price target
- $35.75
- High price target
- $44.00
- Low price target
- $29.00
- Low target gap
- +0.8%
- Target upside
- +24.3%
- High target gap
- +53%
- Target range width
- 52.2%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- September 4, 2026
- Valid through
- September 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Odyssey Therapeutics?
Odyssey Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $35.75.
How far are Odyssey Therapeutics's low and high targets from the recorded price?
The low target implies +0.8%, while the high target implies +53%.
How many analysts are included in Odyssey Therapeutics's consensus?
The verified consensus includes 4 analysts.
How is Odyssey Therapeutics's target upside or downside calculated?
The average target of $35.75 is divided by the recorded price of $28.76, then one is subtracted to produce +24.3%. This does not guarantee a future return.
When was Odyssey Therapeutics's analyst forecast verified?
The data was verified on 2026-09-04. The dataset is valid through 2026-09-11.